Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
[HTML][HTML] Biologics, theranostics, and personalized medicine in drug delivery systems
M Puccetti, M Pariano, A Schoubben… - Pharmacological …, 2024 - Elsevier
The progress in human disease treatment can be greatly advanced through the
implementation of nanomedicine. This approach involves targeted and cell-specific therapy …
implementation of nanomedicine. This approach involves targeted and cell-specific therapy …
Designing antibodies as therapeutics
Antibody therapeutics are a large and rapidly expanding drug class providing major health
benefits. We provide a snapshot of current antibody therapeutics including their formats …
benefits. We provide a snapshot of current antibody therapeutics including their formats …
Modified chitosan: insight on biomedical and industrial applications
Abstract Chitosan (CS), a by–product of chitin deacetylation can be useful in a broad range
of purposes, to mention agriculture, pharmaceuticals, material science, food and nutrition …
of purposes, to mention agriculture, pharmaceuticals, material science, food and nutrition …
[HTML][HTML] Therapeutic antibodies in medicine
P Sharma, RV Joshi, R Pritchard, K Xu, MA Eicher - Molecules, 2023 - mdpi.com
Antibody engineering has developed into a wide-reaching field, impacting a multitude of
industries, most notably healthcare and diagnostics. The seminal work on develo** the …
industries, most notably healthcare and diagnostics. The seminal work on develo** the …
An inhaled ACE2 decoy confers protection against SARS-CoV-2 infection in preclinical models
The Omicron variant continuously evolves under the humoral immune pressure exerted by
vaccination and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …
vaccination and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …
Nanotherapeutics for pulmonary drug delivery: An emerging approach to overcome respiratory diseases
Pulmonary diseases pose an immense threat to global health. Several nanotherapeutics-
based approaches aimed to tackle pulmonary ailments in recent years. The current …
based approaches aimed to tackle pulmonary ailments in recent years. The current …
Monoclonal antibodies in the management of asthma: Dead ends, current status and future perspectives
G Kardas, M Panek, P Kuna, P Damiański… - Frontiers in …, 2022 - frontiersin.org
Patients with moderate-to-severe asthma may now be treated using a variety of monoclonal
antibodies that target key inflammatory cytokines involved in disease pathogenesis. Existing …
antibodies that target key inflammatory cytokines involved in disease pathogenesis. Existing …
Engineered polymer–siRNA polyplexes provide effective treatment of lung inflammation
Uncontrolled inflammation is responsible for acute and chronic diseases in the lung.
Regulating expression of pro-inflammatory genes in pulmonary tissue using small interfering …
Regulating expression of pro-inflammatory genes in pulmonary tissue using small interfering …
Engineering ACE2 decoy receptors to combat viral escapability
T Arimori, N Ikemura, T Okamoto, J Takagi… - Trends in …, 2022 - cell.com
Decoy receptor proteins that trick viruses to bind to them should be resistant to viral escape
because viruses that require entry receptors cannot help but bind decoy receptors …
because viruses that require entry receptors cannot help but bind decoy receptors …
Pulmonary drug delivery: an effective and convenient delivery route to combat COVID-19
The recent outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China has spread
rapidly around the world, leading to a widespread and urgent effort to develop and use …
rapidly around the world, leading to a widespread and urgent effort to develop and use …